Diindolylmethane — DIM (Indole Dimer · Hormonal Balance · Oestrogen Metabolism · Anti-androgenic)

Compound	Diindolylmethane (DIM)
Chemical class	Glucosinolate Condensation Product — Indole Dimer (I3C acid condensation product)
CAS	1968-05-4
Primary source	Acid condensation of I3C (from glucobrassicin in Brassica oleracea) in the stomach
Key applications	Oestrogen receptor modulation, hormonal balance, anti-androgenic, immune function, anticancer research
Claim strength	Moderate
Typical form	DIM isolate; absorption-enhanced DIM (BioResponse® DIM or equivalent); broccoli extract
Buy from Herbuno	Request availability and bulk pricing →

Name origin: Di- (two) + indolyl (indole ring) + methane (the bridging CH2 group connecting the two indole units). DIM is formed when two molecules of I3C condense under gastric acid conditions: 2 × I3C → DIM + H2O. It is the primary endpoint metabolite from glucobrassicin → I3C acid condensation and the most pharmacologically characterised compound in the I3C/DIM metabolic cascade. Traditional use: DIM has no traditional use as an isolated compound — it is a secondary metabolite of dietary cruciferous vegetable consumption, only formed in the stomach during digestion. Its pharmacological significance emerged from I3C research in the 1990s–2000s when DIM was identified as the primary active responsible for many of I3C’s effects. Research trajectory: DIM has multiple human RCTs and pilot studies for hormonal balance (women’s health, PCOS, PMS), prostate health, thyroid function, and immune modulation. It is one of the few phytochemicals with regulatory pathway consideration as a new dietary ingredient (NDI) — the FDA has received NDI notifications for DIM, indicating its established supplement market status. Commercial source: Broccoli extract from Herbuno provides DIM precursors (glucobrassicin → I3C → DIM). See sourcing options below.

---

Evidence for DIM Applications

Oestrogen receptor modulation — hormonal balance: DIM is a dual ERα/ERβ modulator with context-dependent effects. In ER-positive breast cells, DIM demonstrates anti-oestrogenic activity (competitive ERα antagonism, promoting oestradiol metabolism to 2-OHE1). It also modulates progesterone receptor and androgen receptor signalling. Human studies confirm oestrogen metabolite ratio shifts (increased 2-OHE1/16α-OHE1) with DIM supplementation. Claim strength: Moderate (human biomarker studies).

Anti-androgenic — prostate health and PCOS: DIM inhibits androgen receptor transcriptional activity by competing with DHT for AR binding and promoting AR ubiquitination (degradation). Human pilot studies in prostate cancer patients show PSA stabilisation with DIM (100–200 mg/day). Relevant for PCOS (where androgen excess contributes to symptoms) and male hormonal balance. Claim strength: Moderate.

Immune modulation: DIM modulates interferon-γ signalling and T-cell function. In vitro and animal models show immunostimulatory effects in some contexts and immunomodulatory effects in autoimmune contexts. Human immune data are limited but suggest DIM influences innate immune responses. Claim strength: Moderate (mechanistic; limited human data).

HDAC inhibition (epigenetic): DIM inhibits histone deacetylase (HDAC) enzymes, an epigenetic chemopreventive mechanism promoting cancer cell differentiation and apoptosis. HDAC inhibition by DIM is less potent than pharmaceutical HDAC inhibitors but occurs at physiologically relevant concentrations achievable from supplement doses. Claim strength: Moderate.

---

Dosage & Formulator Specification

Human RCT doses: 75–300 mg/day DIM for hormonal and chemopreventive applications. DIM has very poor aqueous solubility and requires absorption enhancement for effective oral bioavailability. Unformulated DIM (plain powder) has bioavailability of approximately 5–10%. Absorption-enhanced formats (BioResponse® DIM with phosphatidylcholine + microcrystalline cellulose; phytosome-DIM) achieve 2–5-fold greater absorption. Always specify absorption-enhanced DIM for supplement applications targeting hormonal effects — standard DIM powder at the same dose delivers far less systemic exposure.

DIM supplements should be taken with a fatty meal to improve lipophilic absorption. DIM interacts with cytochrome P450 enzymes (CYP1A1, CYP1A2 induction; CYP3A4 inhibition at higher doses) — include standard drug interaction advisory for medications metabolised by these enzymes. Headache and changes in urine colour (harmless dark yellow/green from indole metabolites) are the most commonly reported side effects at supplement doses.

---

Frequently Asked Questions — Diindolylmethane

Is DIM better than I3C for hormonal balance?
DIM is the more pharmacologically characterised and more stable compound. At equivalent doses, DIM provides more predictable systemic oestrogen metabolism effects than I3C (which requires variable acid conversion in the stomach). However, I3C generates a broader spectrum of acid-condensation products (DIM + CTet + other oligomers) with additional pharmacological activities (particularly AhR-mediated CYP1A induction from CTet). For targeted oestrogen metabolism and hormonal balance, DIM is preferred; for the complete biological profile of cruciferous vegetable phytochemistry, I3C or broccoli extract (generating both compounds during digestion) may be appropriate.

Can DIM help with PMS or PCOS symptoms?
Human pilot studies show DIM (100–200 mg/day) improves oestrogen metabolite ratios (2-OHE1/16α-OHE1) in women with oestrogen dominance symptoms (PMS, heavy periods, fibrocystic breasts). For PCOS, DIM’s anti-androgenic activity (AR inhibition) addresses the androgen excess component of PCOS alongside oestrogen metabolism improvement. No large randomised trial has specifically evaluated DIM for PMS or PCOS as primary endpoints; the evidence base is from small pilot studies and mechanistic data supporting the hormonal rationale.

Is DIM safe during pregnancy or breastfeeding?
Insufficient data to confirm safety of supplemental DIM doses during pregnancy. DIM’s oestrogen receptor modulation activity is a theoretical concern during pregnancy (where oestrogen signalling is critical). Standard precautionary advisory: avoid DIM supplements during pregnancy and breastfeeding at supplement doses. Dietary cruciferous vegetable consumption (providing physiological DIM levels) is considered safe throughout pregnancy and is recommended as part of a healthy diet.

Does DIM affect thyroid function?
DIM has complex effects on thyroid function. It inhibits thyroid peroxidase at high concentrations in vitro and has been reported to affect thyroid hormone levels in some human cases at supplement doses. Some individuals taking DIM supplements report thyroid function changes. Standard advisory language: monitor thyroid function if using DIM long-term, particularly in individuals with thyroid conditions or on thyroid medications.

Related compounds: Indole-3-Carbinol, Glucobrassicin, Sulforaphane, Allicin

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery